Nacif v. Athira Pharma Inc

District Court, W.D. Washington·Decided February 17, 2023·No. 2:21-cv-00861·Unknown

Opinion

UNITED STATES DISTRICT COURT WESTERN DISTRICT OF WASHINGTON AT SEATTLE ANTONIO BACHAALANI NACIF and WIES RAFI, individually and on behalf of all others similarly situated, Plaintiffs, C21-0861 TSZ v. ORDER ATHIRA PHARMA, INC.; and LEEN KAWAS, Ph.D., Defendants.

THIS MATTER comes before the Court on a motion, docket no. 105, brought by Goldman Sachs & Co. LLC, Jeffries LLC, JMP Securities LLC, and Stifel Nicolaus & Company, Inc. (collectively, “Underwriter Defendants”), seeking entry of a partial judgment pursuant to Federal Rule of Civil Procedure 54(b). Having reviewed all papers filed in support of, and in opposition to, the motion, the Court enters the following Order. Background By Order entered July 29, 2022, docket no. 89, the Court granted in part and denied in part a motion to dismiss brought by defendants Athira Pharma, Inc. (“Athira”), Leen Kawas, Ph.D., Athira’s Chief Financial Officer (“CFO”) Glenna Mileson, Athira’s Board of Directors members Joseph Edelman, John M. Fluke, Jr., and James A. Johnson, and the Underwriter Defendants. See Order (docket no. 89). Of plaintiffs’ five claims, only three were asserted against the Underwriter Defendants, namely (a) plaintiffs’ first claim under § 10(b) of the Securities Exchange Act of 1934 (“Exchange Act”) and U.S. Securities and Exchange Commission Rule 10b-5, (b) plaintiffs’ third claim under

§ 11 of the Securities Act of 1933 (“Securities Act”), and (c) plaintiffs’ fourth claim under § 12 of the Securities Act. See Order at 28–29 (docket no. 89). Plaintiffs’ first claim was dismissed without prejudice and with leave to amend as to Athira and the individual defendants for failure to adequately plead scienter, but with prejudice as to the Underwriter Defendants based on plaintiffs’ clarification that they do not assert a § 10(b) / Rule 10b-5 claim against those four defendants. See id. at 29–32,

38–39, & 42–47. Plaintiffs’ third claim was dismissed without prejudice and with leave to amend, except as to Athira and Dr. Kawas with respect to Statement 3. Id. at 36–42. Plaintiffs’ fourth claim was dismissed with prejudice as to all defendants in light of concessions made by named plaintiffs Antonio Bachaalani Nacif and Wies Rafi. Id. at 29. The following table summarizes the Court’s previous rulings, none of which bind

putative class members. ↓ Defendant | Claim → § 10(b)/Rule 10b-5 § 11 § 12(a)(2) dismissed without Athira Pharma, Inc. prejudice and with dismissed without leave to amend as Leen Kawas, Ph.D. prejudice and with to all statements dismissed with leave to amend except Statement 3 prejudice as to CFO Glenna Mileson ( pf la ei al du r se c t io en a td ee r)q uately dismissed without N (cla ac imif wan itd hd R raa wf ni

Board of Directors prejudice and with by named plaintiffs) (Edelman, Fluke, & Johnson) leave to amend as to all statements dismissed with Underwriter Defs. prejudice In its earlier Order, the Court set a deadline of August 19, 2022, for plaintiffs to file a second amended complaint. See id. at 50. Plaintiffs have not done so. The Court

later set a deadline of December 16, 2022, for joining additional parties. Minute Order at 1 (docket no. 100). No parties have been joined or re-joined. The Underwriter Defendants now ask the Court to enter final judgment in their favor. Defs.’ Mot. (docket no. 105). Plaintiffs oppose the motion, arguing that the dismissal of their § 11 claim is not “final” for purposes of Rule 54(b), and that the current situation does not warrant entry of a partial judgment in favor of the Underwriter Defendants. Pls.’ Resp. (docket

no. 111). Discussion A. Applicable Standards The Court may enter final judgment “as to one or more, but fewer than all, claims or parties” if it “expressly determines” that “no just reason for delay” exists. Fed. R. Civ.

P. 54(b). A decision is “final” if it constitutes “an ultimate disposition of an individual claim.” Curtiss-Wright Corp. v. Gen. Elec. Co., 446 U.S. 1, 7 (1980). Not all final judgments on individual claims in a multiple-claim action should be immediately appealable, and the Court’s role under Rule 54(b) is to serve as a “dispatcher.” Id. at 8. In doing so, the Court must consider both “judicial administrative interests” and “the

equities involved.” See id. The former (juridical) factors include whether the decided claims are “separable from the others remaining to be adjudicated” and “whether the nature of the claims already determined was such that no appellate court would have to decide the same issues more than once even if there were subsequent appeals.” Id. They aim to preserve “the historic federal policy against piecemeal appeals.” Id.; see also Wood v. GCC Bend,

LLC, 422 F.3d 873, 879–82 (9th Cir. 2005) (reversing a Rule 54(b) certification as to the dismissal of constructive discharge claims, which left remaining for trial claims based on an allegedly discriminatory demotion, observing that “[t]he greater the overlap [in facts] the greater the chance that [the Ninth Circuit] will have to revisit the same facts―spun only slightly differently―in a successive appeal”). In evaluating the equities relating to the timing of an appeal, the Court must

engage in a “reasonable” assessment. Curtiss-Wright, 446 U.S. at 10–11. In Curtiss- Wright, the Supreme Court concluded that the district court did not abuse its discretion in considering the difference between the statutory and market rates of interest, as well as the facts that the debts at issue were “liquidated and large” and that, “absent Rule 54(b) certification, the debts would not be paid for ‘many months, if not years’ because the rest

of the litigation would be expected to continue for that period of time.” Id. at 11. The Curtiss-Wright Court eschewed any requirement that economic duress or insolvency be shown to qualify for a partial judgment under Rule 54(b), observing that both parties in the matter were financially sound. Id. at 12. Thus, the district court had properly viewed economic health as a neutral factor in weighing the equities, especially given that it could

and did stay execution on the Rule 54(b) judgment pending appeal. Id. at 12–13 & n.3. B. Proper Scope of Rule 54(b) Certification In asking for entry of a partial judgment in only their favor, the Underwriter Defendants offered no basis for distinguishing between them and the other defendants. If the Court were to certify solely the claims asserted against the Underwriter Defendants, it would be serving up at least two appeals involving the same facts, one now involving the

Underwriter Defendants and another later concerning the other defendants. The Court declines to enter partial judgment in a manner that might require the Ninth Circuit to “decide the same issues on sequential appeals rather than once as a single unit.” See Abdo v. Fitzsimmons, Nos. 17-cv-851 & 17-cv-1232, 2021 WL 3493169, at *3 (N.D. Cal. May 17, 2021). The procedural posture of this case, however, might support a broader Rule 54(b)

certification. With regard to the § 10(b) / Rule 10b-5 claim against the Underwriter Defendants and the § 12 claim against all defendants, the dismissal was premised on plaintiffs’ withdrawal of the claims, and no appeal is anticipated. With regard to plaintiffs’ Exchange Act claims against all defendants other than the Underwriter Defendants, the basis for dismissal, namely the failure to adequately plead scienter, does

Free access — add to your briefcase to read the full text and ask questions with AI

Nacif v. Athira Pharma Inc, (W.D. Wash. 2023).

Nacif v. Athira Pharma Inc (Nacif v. Athira Pharma Inc) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related